NHLBI Catalyze R33: Validate Enabling Technologies & Platforms for HLBS Research (No Clinical Trials)
This R33 NOFO from the NHLBI Catalyze program funds mid-stage (TRL 3–4) development and rigorous validation of transformative, multi-use enabling technologies or platforms that broadly advance heart, lung, blood, and sleep (HLBS) research. Applications must have supportive preliminary data showing feasibility (first-generation prototypes), focus on platform capabilities rather than single-dise…
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research
The NHLBI Catalyze innovation program is designed to provide a suite of comprehensive support and services to facilitate the transition of basic science discoveries into new treatments for diseases and disorder…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic organizations are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are eligible to apply, and foreign components (as defined in the NIH Grants Policy Statement) are allowed in applications from eligible U.S. organizations.
Required regis…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers